ArticleJournal of experimental & clinical cancer research : CR2020

Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma.

Runhua Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.